Jeffrey Kraws
Président chez THERIVA BIOLOGICS, INC.
Fortune : 328 121 $ au 31/12/2023
Profil
Jeffrey J.
Kraws is the founder of TopHat Capital LLC (founded in 2012) where he holds the title of Partner.
He is also the founder of Cra Advisors LLC (founded in 2003) where he holds the title of Chief Executive Officer.
Additionally, he was the founder of Crystal Research Associates (founded in 2003) where he held the title of Chief Executive Officer.
Mr. Kraws currently holds the position of Independent Non-Executive Chairman at Theriva Biologics, Inc. since 2006.
He is also a Partner at Phoenix Holdings Ltd.
(US) since 2015 and a Partner at Grannus Securities Pty Ltd.
since 2015.
Furthermore, he is a Partner at US Medical Innovations LLC and serves as the Chief Financial Officer at Syncromune, Inc.Mr. Kraws has held former positions as the Independent Chairman at Avivagen, Inc. from 2013 to 2023.
He was also a Managing Director-Healthcare Research at Ryan, Beck & Co., Inc. He served as a Director at Saleen Automotive, Inc. from 2013 to 2020.
Additionally, he was the Managing Director & Research Director at Gruntal & Co. LLC.
He held the position of Director at Innovation1 Biotech, Inc. from 2021 to 2023.
He was a Senior Analyst at The Buckingham Research Group, Inc. and an MD-Healthcare Research Group at First Union Securities.
He served as the President of IRG Research Group and Co-President of The Investor Relations Group, Inc. He was the President of Ra Medical Systems, Inc. from 2016 to 2021 and the President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc.Mr. Kraws obtained an MBA from Cornell University in 1988 and an undergraduate degree from State University of New York at Buffalo in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNOVATION1 BIOTECH INC
6,79% | 12/01/2024 | 1 389 055 ( 6,79% ) | 327 817 $ | 31/12/2023 |
THERIVA BIOLOGICS, INC.
0,00% | 25/03/2024 | 654 ( 0,00% ) | 154 $ | 30/06/2024 |
AVIVAGEN INC.
0,06% | 03/03/2023 | 50 000 ( 0,06% ) | 150 $ | 30/06/2024 |
Postes actifs de Jeffrey Kraws
| Sociétés | Poste | Début |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Président | 14/05/2012 |
Phoenix Holdings Ltd. (US)
 Phoenix Holdings Ltd. (US) Multi-Line InsuranceFinance Part of Delek Group Ltd., Phoenix Holdings Ltd. (US) is a company that provides financial services. The company is based in Austin, TX. | Corporate Officer/Principal | 01/11/2015 |
US Medical Innovations LLC
 US Medical Innovations LLC Medical SpecialtiesHealth Technology Part of US Patent Innovations LLC, US Medical Innovations LLC is a privately held FDA registered life science, biomedical and robotic device company based in Takoma Park, MD. US Medical Innovations is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives. The company develops products for laparoscopic, robotic and cancer surgeries. The company was founded in 2009 by Jerome Canady and Kimberly Wiley, with Jerome Canady serving as CEO since then. | Corporate Officer/Principal | - |
Cra Advisors LLC
 Cra Advisors LLC Investment ManagersFinance Cra Advisors LLC provides investment advisory services. The private company is based in New York. The American company was founded by Jeffrey J. Kraws. Jeffrey J. Kraws has been the CEO since incorporation. | Directeur Général | 01/01/2003 |
| Grannus Securities Pty Ltd. | Corporate Officer/Principal | 01/11/2015 |
TopHat Capital LLC
 TopHat Capital LLC Financial ConglomeratesFinance TopHat Capital LLC is a financial services firm that operates as an execution-based company. The private company is based in New York, NY. The company was founded by Jeffrey J. Kraws. | Fondateur | 01/02/2012 |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Directeur Financier/CFO | - |
Anciens postes connus de Jeffrey Kraws
| Sociétés | Poste | Fin |
|---|---|---|
| INNOVATION1 BIOTECH INC. | Directeur Général | 06/12/2022 |
| AVIVAGEN INC. | Président | 01/04/2023 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Kraws
| Cornell University | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| AVIVAGEN INC. | Health Technology |
| INNOVATION1 BIOTECH INC. | Retail Trade |
| Entreprise privées | 16 |
|---|---|
Crystal Research Associates
 Crystal Research Associates Investment ManagersFinance Headquartered in New York City, Crystal Research Associates is an independent research company dedicated to increasing the visibility of innovative and growing private and public companies. They focus on companies demonstrating solid growth prospects, well-designed operating and growth strategies, an experienced and proven management team, command of a niche position in a large and expanding market, and a unique or innovative position or technology. The firm was founded in 2003 | Finance |
| IRG Research Group | Finance |
Ryan, Beck & Co., Inc.
 Ryan, Beck & Co., Inc. Investment Banks/BrokersFinance Ryan, Beck & Co., Inc. was founded in 1946. They are headquartered in Florham Park, New Jersey with additional offices in Atlanta, Georgia, Boca Raton, Florida, Conshohocken, Pennsylvania, New York City, and Richmond, Virginia. | Finance |
| First Union Securities | Finance |
The Buckingham Research Group, Inc.
 The Buckingham Research Group, Inc. Investment Banks/BrokersFinance Founded in 1982, Buckingham Research Group, Inc. is an institutional brokerage firm located in New York City. The firm provides services to portfolio managers and research analysts for mutual funds, hedge funds, pension funds, foundations and other institutional investors. The employ fundamental, bottom-up research with a focus on U.S. small- to mid-cap emerging growth companies in the retail, consumer non-durables, finance and technology sectors | Finance |
The Investor Relations Group, Inc.
 The Investor Relations Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Investor Relations Group, Inc. provided investor relations and public relations services to nano, micro and small-cap companies. The company was founded by Dian Griesel on October 1, 1996 and was headquartered in New York, NY. | Commercial Services |
| Gruntal & Co. LLC | Government |
TopHat Capital LLC
TopHat Capital LLC Financial ConglomeratesFinance TopHat Capital LLC is a financial services firm that operates as an execution-based company. The private company is based in New York, NY. The company was founded by Jeffrey J. Kraws. | Finance |
| Grannus Securities Pty Ltd. | |
Phoenix Holdings Ltd. (US)
Phoenix Holdings Ltd. (US) Multi-Line InsuranceFinance Part of Delek Group Ltd., Phoenix Holdings Ltd. (US) is a company that provides financial services. The company is based in Austin, TX. | Finance |
Ra Medical Systems, Inc.
 Ra Medical Systems, Inc. Medical SpecialtiesHealth Technology Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Fort Mill, SC. | Health Technology |
Cra Advisors LLC
Cra Advisors LLC Investment ManagersFinance Cra Advisors LLC provides investment advisory services. The private company is based in New York. The American company was founded by Jeffrey J. Kraws. Jeffrey J. Kraws has been the CEO since incorporation. | Finance |
| Abb Aros Securities, Inc. | |
Saleen Automotive, Inc.
 Saleen Automotive, Inc. Specialty StoresRetail Trade Saleen Automotive, Inc. manufactures equipment for sports cars. It also designs, develops, manufactures and sells vehicles built from the base chassis of major American automobile manufacturers. Its branded products include upgraded muscle and electric cars, automotive aftermarket specialty parts and lifestyle accessories. The company was founded by Wesley E. Fry and Stephen M. Saleen in July 2007 and is headquartered in Corona, CA. | Retail Trade |
US Medical Innovations LLC
US Medical Innovations LLC Medical SpecialtiesHealth Technology Part of US Patent Innovations LLC, US Medical Innovations LLC is a privately held FDA registered life science, biomedical and robotic device company based in Takoma Park, MD. US Medical Innovations is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives. The company develops products for laparoscopic, robotic and cancer surgeries. The company was founded in 2009 by Jerome Canady and Kimberly Wiley, with Jerome Canady serving as CEO since then. | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
